LifeMD (LFMD) Cash from Discontinued Operations (2017 - 2018)

LifeMD's (LFMD) quarterly Cash from Discontinued Operations came in at 323785.0 in Q4 2018, down 326.74% on a QoQ basis from 142799.0 in Q3 2018.

LifeMD (LFMD) Cash from Discontinued Operations (2017 - 2018) Analysis & Trends

LifeMD (LFMD) has 2 years of Cash from Discontinued Operations data on file, last reported at 323785.0 in Q4 2018.

Quarterly Cash from Discontinued Operations changed N/A year-over-year to 323785.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was 40498.0 (changed N/A YoY) and the FY2025 annual result came in at 6207871.0, up 97.08% from the prior year.
Cash from Discontinued Operations declined to 323785.0 in Q4 2018, from 142799.0 in the prior quarter.
In the past five years, Cash from Discontinued Operations ranged from a high of 171076.0 in Q1 2018 to a low of 323785.0 in Q4 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Discontinued Operations (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn	-
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn	-
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn	-
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn	-
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn	-
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn	-
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn	-
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn	-
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn	-
10	LifeMD	160.97 Mn	123.85 Mn	2.85 Mn	-

Download Data